TR201200215A2 - Geliştirilmiş farmasötik formülasyonlar. - Google Patents
Geliştirilmiş farmasötik formülasyonlar.Info
- Publication number
- TR201200215A2 TR201200215A2 TR2012/00215A TR201200215A TR201200215A2 TR 201200215 A2 TR201200215 A2 TR 201200215A2 TR 2012/00215 A TR2012/00215 A TR 2012/00215A TR 201200215 A TR201200215 A TR 201200215A TR 201200215 A2 TR201200215 A2 TR 201200215A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical formulations
- improved pharmaceutical
- improved
- alendronate
- prevention
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 229940062527 alendronate Drugs 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılacak alendronat içeren farmasötik formülasyonlara ilişkindir.@
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2012/00215A TR201200215A2 (tr) | 2011-01-06 | 2012-01-06 | Geliştirilmiş farmasötik formülasyonlar. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/00153A TR201100153A2 (tr) | 2011-01-06 | 2011-01-06 | Efervesan bifosfonat formülasyonları. |
| TR2012/00215A TR201200215A2 (tr) | 2011-01-06 | 2012-01-06 | Geliştirilmiş farmasötik formülasyonlar. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201200215A2 true TR201200215A2 (tr) | 2012-07-23 |
Family
ID=45771873
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/00153A TR201100153A2 (tr) | 2011-01-06 | 2011-01-06 | Efervesan bifosfonat formülasyonları. |
| TR2012/00214A TR201200214A2 (tr) | 2011-01-06 | 2012-01-06 | Alendronat içeren farmasötik granüller. |
| TR2012/00216A TR201200216A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine tedavi paketi. |
| TR2012/00215A TR201200215A2 (tr) | 2011-01-06 | 2012-01-06 | Geliştirilmiş farmasötik formülasyonlar. |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/00153A TR201100153A2 (tr) | 2011-01-06 | 2011-01-06 | Efervesan bifosfonat formülasyonları. |
| TR2012/00214A TR201200214A2 (tr) | 2011-01-06 | 2012-01-06 | Alendronat içeren farmasötik granüller. |
| TR2012/00216A TR201200216A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine tedavi paketi. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2661257B1 (tr) |
| TR (4) | TR201100153A2 (tr) |
| WO (1) | WO2012093978A1 (tr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196315B (it) | 1984-10-29 | 1988-11-16 | Gentili Ist Spa | Procedimento per la preparazione di acidi difosfonici |
| TR200900880A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik bileşimler. |
-
2011
- 2011-01-06 TR TR2011/00153A patent/TR201100153A2/tr unknown
-
2012
- 2012-01-06 TR TR2012/00214A patent/TR201200214A2/tr unknown
- 2012-01-06 WO PCT/TR2012/000009 patent/WO2012093978A1/en not_active Ceased
- 2012-01-06 TR TR2012/00216A patent/TR201200216A2/tr unknown
- 2012-01-06 EP EP12706345.1A patent/EP2661257B1/en active Active
- 2012-01-06 TR TR2012/00215A patent/TR201200215A2/tr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201200216A2 (tr) | 2012-07-23 |
| EP2661257A1 (en) | 2013-11-13 |
| TR201100153A2 (tr) | 2012-07-23 |
| TR201200214A2 (tr) | 2012-07-23 |
| EP2661257B1 (en) | 2017-11-15 |
| WO2012093978A1 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00948A (tr) | ||
| UY33863A (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| EP3466408C0 (en) | LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE OF THE POSTERIOR EYE | |
| TW201129382A (en) | Antibody formulation and therapeutic regimens | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| HUE039864T2 (hu) | Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére | |
| EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
| EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
| EA201391719A1 (ru) | Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| IN2014MN00987A (tr) | ||
| SMT201400150B (it) | Composizioni terapeutiche comprendenti rilpivirinacloridrato e tenofovir disoproxil fumarato | |
| MX2012013731A (es) | Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas. | |
| EP2849738C0 (en) | HIGH PENETRATION PRODRUG COMPOSITIONS AND ASSOCIATED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY CONDITIONS | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| HUE053409T2 (hu) | Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére | |
| PL2582366T3 (pl) | Kombinacja farmaceutyczna do leczenia bólu | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| EA201201296A1 (ru) | Способы лечения диабетических язв стопы | |
| PL2718434T3 (pl) | Kompozycje i sposoby leczenia choroby trzewnej | |
| EA201270728A1 (ru) | Пуриновые соединения |